Worst Case Scenario: Potential Pitfalls of the New System

The new agreed proposal on Medical devices and In-vitro diagnostics introduces new concepts, new definitions, new scope, obligations and roles of economic operators...  In theory, the aim of the legislator is to reinforce the regulatory framework of MD and IVD in the EU. In practice, what could be the potential side effect(s) of those regulatory changes ?